Conclusion:
Although it is a confusing question which patients are at risk of myocarditis after the COVID-19 vaccines, given the protective role of these vaccines against COVID-19 mortality, it is certain that this limited and curative side effect is not a cause for hessitation in vaccination. And it would be beneficial for the cardiologists who perform the primary follow-up of these patients to know that it is possible with SE to support the diagnosis and follow these patients, even if CMR is not accesible.